Topics
modish
AI
Amazon
Image Credits:Svisio / Getty Images
Apps
Biotech & Health
Climate
Image Credits:Svisio / Getty Images
Cloud Computing
Commerce
Crypto
go-ahead
EVs
Fintech
fund raise
Gadgets
Gaming
Government & Policy
computer hardware
Layoffs
Media & Entertainment
Meta
Microsoft
Privacy
Robotics
Security
Social
Space
Startups
TikTok
transit
Venture
More from TechCrunch
Events
Startup Battlefield
StrictlyVC
Podcasts
picture
Partner Content
TechCrunch Brand Studio
Crunchboard
reach Us
Isomorphic Labs , the AI drug - breakthrough platform that wasspun out of Google ’s DeepMindin 2021 , has raised outside majuscule for the first meter . The $ 600 million round was led by Thrive Capital , with involution from GV and existing investor Alphabet , Google ’s parent , it said .
The financial support will accelerate further ontogenesis of Isomorphic ’s AI drug design railway locomotive and support the society ’s destination of bringing its happen upon drug to clinical trials .
Isomorphic Labs was founded by DeepMind co - founding father Demis Hassabis by leveraging DeepMind ’s package for AI drug uncovering , including AlphaFold , an AI simulation that predicts the three - dimensional structures of protein .
Last year , Isomorphic Labs secured strategical partnerships with Eli Lilly and Novartis , potentiallygenerating up to $ 3 billionin milestone requital for access to its AI theoretical account .
Hassabis toldthe New York Timesthat while Isomorphic Labs did n’t need the capital , the supernumerary funding will help oneself the partitioning hire top enquiry scientists .
For their oeuvre on AlphaFold , Hassabis and DeepMind investigator John Jumper were among the three scientist who received aNobel Prize in chemistryin 2024 .
